Tempest Therapeutics Starts Phase I/Ib Clinical Trial with First-in-Class PPAR Alpha Antagonist May 16, 2019
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products May 15, 2019
FDA Approves TraceLink DSCSA Pilot Submission for Network Solutions; Delivering 2023 Traceability By Leveraging Blockchain and Digital Recalls Across a Supply Network May 14, 2019
Baptist Health Partners with PatientPing, Enabling Real-Time Care Coordination Across Acute and Post-Acute Care Settings May 14, 2019
Semma Therapeutics Announces Publication in Nature Demonstrating Advancements in Regenerative Cell Therapy for Type 1 Diabetes May 8, 2019
FARAPULSE Receives FDA Breakthrough Designation for its Endocardial Pulsed Field Ablation System May 8, 2019
Science2Startup Symposium Convened Close to 300 Academic Researchers, Venture Capitalists, Entrepreneurs, and Pharmaceutical Executives, Creating Connections to Advance Scientific Innovation and Entrepreneurship May 7, 2019